Delpor, Inc.

Delpor is a clinical stage life sciences company that utilizes innovative drug-delivery technologies in order to develop once-yearly therapies for chronic conditions. The Company’s lead product is a 6-12-month formulation of Risperidone (drug/device combination product) for the treatment of schizophrenia. Delpor is also pursuing 6-12 month formulations of other drugs targeting CNS conditions including Neuromuscular Diseases, Neurodegenerative Diseases, Addiction, and other disorders.

网站

http://delpor.com

Delpor, Inc.的外部链接

所属行业

生物技术

规模

11-50 人

总部

Brisbane，CA

类型

私人持股

创立

2009

领域

Drug Delivery、Biotech、Scizophrenia、Diabetes、Mental Illnesses、Research and Development、Nanotechnology、Peptides、Proteins和Small Molecules